Clinical Trials Browser

Phase 1 × OTHER × NY-ESO-1-expressing Tumors × Clear all

NCT00819806 2017-07-31

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

Phase 1 Completed

NY-ESO-1-expressing Tumors